Emmaus Life Sciences (Emmaus Life Sciences) EV-to-EBIT : 19.60 (As of Apr. 29, 2024)

Emmaus Life Sciences EV-to-EBIT Chart

Emmaus Life Sciences Annual Data
	Trend	Sep13	Sep14	Sep15	Sep16	Sep17	Sep18	Dec19	Dec20	Dec21	Dec22
EV-to-EBIT		Get a 7-Day Free Trial					-0.81	-3.15	11.03	-7.99	-7.51

Emmaus Life Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EV-to-EBIT	Get a 7-Day Free Trial															-3.09	-7.51	-7.52	44.31	20.27

Competitive Comparison of Emmaus Life Sciences's EV-to-EBIT

For the Biotechnology subindustry, Emmaus Life Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emmaus Life Sciences's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Emmaus Life Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Emmaus Life Sciences's EV-to-EBIT falls into.

Emmaus Life Sciences EV-to-EBIT Calculation

Emmaus Life Sciences's EV-to-EBIT for today is calculated as:

Emmaus Life Sciences's current Enterprise Value is $39.20 Mil.
Emmaus Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmaus Life Sciences  (OTCPK:EMMA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Emmaus Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Emmaus Life Sciences's Enterprise Value for the quarter that ended in Sep. 2023 was $40.54 Mil.
Emmaus Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmaus Life Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Emmaus Life Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Emmaus Life Sciences (Emmaus Life Sciences) Business Description